Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Joanne, Jeter"'
Autor:
Shivani Patel, Heather Armbruster, Gretchen Pardo, Brianna Archambeau, Na Hyun Kim, Joanne Jeter, Richard Wu, Kari Kendra, Carlo M Contreras, Natalie Spaccarelli, Brittany Dulmage, Llana Pootrakul, David R Carr, Claire Verschraegen
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0297531 (2024)
Basal cell carcinoma (BCC) is highly curable by surgical excision or radiation. In rare cases, BCC can be locally destructive or difficult to surgically remove. Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50-60% response rate. Lo
Externí odkaz:
https://doaj.org/article/01d536bfa26f4f6ca7f8d0a675155ffa
Autor:
Lauren Gima, Christina Fujii, Michael Restrepo, Christina Rybak, Elise Sobotka, Elyssa Zukin, Lawrence Shaktah, Joanne Jeter, Kevin McDonnell, Wai Park, Gregory Idos, Heather Hampel, Stacy Gray
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 100941- (2024)
Externí odkaz:
https://doaj.org/article/db9d78d0e0344c729cb3869bdadfd2e4
Autor:
John Marsiglio, Jordan P. McPherson, Magdalena Kovacsovics-Bankowski, Joanne Jeter, Christos Vaklavas, Umang Swami, Douglas Grossmann, Alyssa Erickson-Wayman, Heloisa P. Soares, Katie Kerrigan, Berit Gibson, Jennifer Anne Doherty, John Hyngstrom, Sheetal Hardikar, Siwen Hu-Lieskovan
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundType 1 diabetes mellitus (T1DM) is a rare, but serious immune-related adverse event (irAE) of immune checkpoint inhibitors (ICIs). Our goal was to characterize treatment outcomes associated with ICI-induced T1DM through analysis of clinical
Externí odkaz:
https://doaj.org/article/33e51152bcc24a469b71e51e480b2741
Autor:
Shaheer Khan, Jose Lutzky, Alexander N. Shoushtari, Joanne Jeter, Brian Marr, Thomas E. Olencki, Colleen M. Cebulla, Mohamed Abdel-Rahman, J. William Harbour, Naomi Sender, Alexandra Nesson, Shahnaz Singh-Kandah, Susana Hernandez, Jeanelle King, Manpreet S. Katari, Lyssa Dimapanat, Stephanie Izard, Grazia Ambrosini, Oliver Surriga, Alex J. Rai, Codruta Chiuzan, Gary K. Schwartz, Richard D. Carvajal
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionApproximately 40% of patients with uveal melanoma (UM) will develop metastatic disease. Tumors measuring at least 12mm in basal diameter with a class 2 signature, as defined by a widely used gene expression-profiling test, are associated
Externí odkaz:
https://doaj.org/article/6d9c9f02602b4cf392e58ac3bafdaab3
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Although most non-melanoma skin cancers are felt to be sporadic in origin, these tumors do play a role in several cancer predisposition syndromes. The manifestations of skin cancers in these hereditary populations can include diagnosis at extremely e
Externí odkaz:
https://doaj.org/article/4c4f91c2b9624a39ba5e12d543f141e4
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The largest proportion of hereditary melanoma cases are due to pathogenic variants (PVs) in the CDKN2A/p16 gene, which account for 20%-40% of familial melanomas and confer up to a 30%-70% lifetime risk for melanoma in individuals with these variants.
Externí odkaz:
https://doaj.org/article/f8a9ecfa77fd4540b1f4bff461b9e9a8
This study aimed to estimate the incremental lifetime effects, costs, and net monetary benefit (NMB) of knowing BRCA information for recurrent ovarian cancer (ROC) patients in a given year and the cumulative savings of yearly hypothetical cohort test
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e38deabf3ad844260261680be7b9572
This study aimed to estimate the incremental lifetime effects, costs, and net monetary benefit (NMB) of knowing BRCA information by universal genetic testing of all US women without breast cancer turning 40 in a given year, and the cumulative savings
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::957b129204b7e961b3656c82719ab6fa
Autor:
Whitney, Espinel, Marjan, Champine, Heather, Hampel, Joanne, Jeter, Kevin, Sweet, Robert, Pilarski, Rachel, Pearlman, Kate, Shane, Pamela, Brock, Judith A, Westman, Lindsay, Kipnis, Jilliane, Sotelo, Anu, Chittenden, Samantha, Culver, Jill E, Stopfer, Katherine A, Schneider, Rosalba, Sacca, Diane R, Koeller, Shraddha, Gaonkar, Erica, Vaccari, Sarah, Kane, Scott T, Michalski, Shan, Yang, Sarah M, Nielsen, Sara L, Bristow, Stephen E, Lincoln, Robert L, Nussbaum, Edward D, Esplin
Publikováno v:
Cancers. 14(10)
Consensus guidelines for hereditary breast and ovarian cancer include management recommendations for pathogenic/likely pathogenic (P/LP) variants in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24cf0bd64bd4582859098cbce772d872
https://pubmed.ncbi.nlm.nih.gov/35626031
https://pubmed.ncbi.nlm.nih.gov/35626031
Autor:
Mitchell L. Ramsey, Jewel Tomlinson, Rachel Pearlman, Laith Abushahin, Amber Aeilts, Hui-Zi Chen, Yan Chen, Ashley Compton, Rifat Elkhatib, Levi Geiger, John Hays, Joanne Jeter, Ning Jin, Pannaga Malalur, Sameek Roychowdhury, Jessica Ruple, Jennifer Prebish, Peter P. Stanich, Heather Hampel
Publikováno v:
Familial cancer.
Germline genetic testing is recommended for all patients with pancreatic cancer (PC) but uptake rates are low. We implemented a mainstreaming program in oncology clinics to increase testing for PC patients. Genetic counselors trained oncology provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5727608a79dd6f3fbb9faa15407e5ebb
https://pubmed.ncbi.nlm.nih.gov/35713757
https://pubmed.ncbi.nlm.nih.gov/35713757